Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP959394.RAO17HOdC5g9BxOJjOZEBL-1_XOrnSimhPFdrLVRJtkTs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP959394.RAO17HOdC5g9BxOJjOZEBL-1_XOrnSimhPFdrLVRJtkTs130_assertion type Assertion NP959394.RAO17HOdC5g9BxOJjOZEBL-1_XOrnSimhPFdrLVRJtkTs130_head.
- NP959394.RAO17HOdC5g9BxOJjOZEBL-1_XOrnSimhPFdrLVRJtkTs130_assertion description "[Moreover, real-time quantitative RT-PCR showed that the expression levels of preproAM (+548%), preproAM2/IMD (+2674%), calcitonin receptor-like receptor (CLR) (+518%), receptor activity modifying protein (RAMP)2 (+281%), RAMP3 (+178%), VEGF-A (+277%) and MMP-9 (+864%) mRNAs were significantly higher in cancer tissues than in the surrounding normal tissues, and there was a positive correlation between the gene expressions of MMP-9 and preproAM (r=0.352; p=0.005), but not with preproAM2/IMD (r=0.041, p=0.406).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP959394.RAO17HOdC5g9BxOJjOZEBL-1_XOrnSimhPFdrLVRJtkTs130_provenance.
- NP959394.RAO17HOdC5g9BxOJjOZEBL-1_XOrnSimhPFdrLVRJtkTs130_assertion evidence source_evidence_literature NP959394.RAO17HOdC5g9BxOJjOZEBL-1_XOrnSimhPFdrLVRJtkTs130_provenance.
- NP959394.RAO17HOdC5g9BxOJjOZEBL-1_XOrnSimhPFdrLVRJtkTs130_assertion SIO_000772 21839130 NP959394.RAO17HOdC5g9BxOJjOZEBL-1_XOrnSimhPFdrLVRJtkTs130_provenance.
- NP959394.RAO17HOdC5g9BxOJjOZEBL-1_XOrnSimhPFdrLVRJtkTs130_assertion wasDerivedFrom befree-20150227 NP959394.RAO17HOdC5g9BxOJjOZEBL-1_XOrnSimhPFdrLVRJtkTs130_provenance.
- NP959394.RAO17HOdC5g9BxOJjOZEBL-1_XOrnSimhPFdrLVRJtkTs130_assertion wasGeneratedBy ECO_0000203 NP959394.RAO17HOdC5g9BxOJjOZEBL-1_XOrnSimhPFdrLVRJtkTs130_provenance.